Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
CardioRenal receives FDA Breakthrough Device Designation for TENOR
CardioRenal, a pioneer in the remote treatment of patients with severe chronic kidney disease (CKD), […]
Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
Healthy.io, the global leader in transforming the smartphone camera into a medical device, today announced […]
XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease
XORTX Therapeutics, a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive […]
Jesduvroq Approved by US FDA for Anaemia of Chronic Kidney Disease in Adults on Dialysis
GSK today announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), […]
Modus Therapeutics Submits Patent Application for Sevuparin in Kidney Disease
Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet medical […]
US FDA Accepts Supplemental New Drug Application for Jardiance® for Adults with Chronic Kidney Disease
The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more